Session

PP 05 IBD (Posters)

EFFICACY, SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) MONOTHERAPY VERSUS COMBINATION THERAPY WITH IMMUNOSUPPRESSANTS – POST HOC ANALYSIS OF LIBERTY-CD STUDY AND LIBERTY-UC STUDY
EFFICACY, SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) MONOTHERAPY VERSUS COMBINATION THERAPY WITH IMMUNOSUPPRESSANTS – POST HOC ANALYSIS OF LIBERTY-CD STUDY AND LIBERTY-UC STUDY

EFFICACY AND SAFETY OF PROACTIVE DRUG MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE DURING MAINTENANCE TREATMENT WITH ANTI-TNF AGENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
EFFICACY AND SAFETY OF PROACTIVE DRUG MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE DURING MAINTENANCE TREATMENT WITH ANTI-TNF AGENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

INVESTIGATING THE ROLE OF GUT EUKARYOTIC VIROME IN CONTRIBUTING TO COLORECTAL CANCER CARCINOGENESIS
INVESTIGATING THE ROLE OF GUT EUKARYOTIC VIROME IN CONTRIBUTING TO COLORECTAL CANCER CARCINOGENESIS

EFFECT OF TOFACITINIB ON COLECTOMY RISK IN ANTI TNF-ALFA REFRACTORY ULCERATIVE COLITIS
EFFECT OF TOFACITINIB ON COLECTOMY RISK IN ANTI TNF-ALFA REFRACTORY ULCERATIVE COLITIS

VACCINATIONS IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES, PATIENT KNOWLEDGE AND AWARENESS: RESULTS FROM A NORDIC SURVEY
VACCINATIONS IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES, PATIENT KNOWLEDGE AND AWARENESS: RESULTS FROM A NORDIC SURVEY

« WORK ABILITY INDEX » AS A SUITABLE INSTRUMENT TO ASSESS WORK ABILITY AMONG IBD PATIENTS
« WORK ABILITY INDEX » AS A SUITABLE INSTRUMENT TO ASSESS WORK ABILITY AMONG IBD PATIENTS

INFLAMMATORY BOWEL DISEASE AND IMPAIRMENT OF WORKING LIFE
INFLAMMATORY BOWEL DISEASE AND IMPAIRMENT OF WORKING LIFE

THE DUBLIN SCORE: A NEW VISION FOR ASSESSMENT OF ULCERATIVE COLITIS
THE DUBLIN SCORE: A NEW VISION FOR ASSESSMENT OF ULCERATIVE COLITIS

TIME TRENDS OF ENVIRONMENTAL AND SOCIOECONOMIC RISK FACTORS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE OVER 40 YEARS OF DIFFERENT THERAPEUTIC ERAS: A POPULATION-BASED COHORT BETWEEN 1977-2020
TIME TRENDS OF ENVIRONMENTAL AND SOCIOECONOMIC RISK FACTORS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE OVER 40 YEARS OF DIFFERENT THERAPEUTIC ERAS: A POPULATION-BASED COHORT BETWEEN 1977-2020

APPLICATION OF THE NUTRITIONAL RISK INDEX IN NUTRITIONAL ASSESSMENT OF PATIENTS WITH CROHN’S DISEASE
APPLICATION OF THE NUTRITIONAL RISK INDEX IN NUTRITIONAL ASSESSMENT OF PATIENTS WITH CROHN’S DISEASE

VISUALIZATION OF DNA DAMAGE RESPONSE AND ITS ASSOCIATION WITH CLINICOPATHOLOGICAL FEATURES IN ULCERATIVE COLITIS
VISUALIZATION OF DNA DAMAGE RESPONSE AND ITS ASSOCIATION WITH CLINICOPATHOLOGICAL FEATURES IN ULCERATIVE COLITIS

TRANSMURAL CROSS-SECTIONAL FINDINGS AND BOWEL DAMAGE ASSESSMENT IN PRECLINICAL CROHN’S DISEASE: A CASE-CONTROL STUDY
TRANSMURAL CROSS-SECTIONAL FINDINGS AND BOWEL DAMAGE ASSESSMENT IN PRECLINICAL CROHN’S DISEASE: A CASE-CONTROL STUDY

FACILITATING EQUITABLE IBD CARE TRUST-WIDE: A NEED FOR TREATMENT TARGETS IN IBD?
FACILITATING EQUITABLE IBD CARE TRUST-WIDE: A NEED FOR TREATMENT TARGETS IN IBD?

CAPSULE ENTEROSCOPY PROXIMAL SMALL-BOWEL INFLAMMATION IN CROHN’S DISEASE IS ASSOCIATED WITH MORE SEVERE MUCOSAL INJURY AND NEED FOR TREATMENT WITH BIOLOGICS
CAPSULE ENTEROSCOPY PROXIMAL SMALL-BOWEL INFLAMMATION IN CROHN’S DISEASE IS ASSOCIATED WITH MORE SEVERE MUCOSAL INJURY AND NEED FOR TREATMENT WITH BIOLOGICS

ENDOSCOPIC, HISTOLOGICAL AND SEROLOGICAL ASSESSMENTS OF DISEASE ACTIVITY IN UC
ENDOSCOPIC, HISTOLOGICAL AND SEROLOGICAL ASSESSMENTS OF DISEASE ACTIVITY IN UC

COVID-19 OUTCOME AND ASSOCIATION TO ANTI-SPIKE ANTIBODY CONCENTRATIONS IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY; A PROSPECTIVE COHORT STUDY
COVID-19 OUTCOME AND ASSOCIATION TO ANTI-SPIKE ANTIBODY CONCENTRATIONS IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY; A PROSPECTIVE COHORT STUDY

VIDEO CAPSULE ENDOSCOPY MAY DETECT ACTIVE SMALL BOWEL CROHN’S DISEASE REQUIRING CHANGE OF TREATMENT DESPITE UNREMARKABLE ILEO-COLONIC ANASTOMOSIS
VIDEO CAPSULE ENDOSCOPY MAY DETECT ACTIVE SMALL BOWEL CROHN’S DISEASE REQUIRING CHANGE OF TREATMENT DESPITE UNREMARKABLE ILEO-COLONIC ANASTOMOSIS

CHARACTERISTICS AND MANAGEMENT OF PYODERMA GANGRENOSUM AND ERYTHEMA NODOSUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PIONOSO MULTICENTER STUDY
CHARACTERISTICS AND MANAGEMENT OF PYODERMA GANGRENOSUM AND ERYTHEMA NODOSUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PIONOSO MULTICENTER STUDY

COMBINATION OF GRANULOCYTE–MONOCYTE APHERESIS AND TOFACITINIB: MULTICENTRE AND RETROSPECTIVE STUDY
COMBINATION OF GRANULOCYTE–MONOCYTE APHERESIS AND TOFACITINIB: MULTICENTRE AND RETROSPECTIVE STUDY

SINGLE-CELL TRANSCRIPTOMIC ANALYSIS IDENTIFIES EARLY IMMUNE DISTURBANCES IN PRECLINICAL CROHN'S DISEASE
SINGLE-CELL TRANSCRIPTOMIC ANALYSIS IDENTIFIES EARLY IMMUNE DISTURBANCES IN PRECLINICAL CROHN'S DISEASE

Item 801 - 820 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
41
42